NAUT - Nautilus Biotechnology, Inc. Stock Price and Quote

NAUT [NASD]

Index	-	P/E	-	EPS (ttm)	-0.47	Insider Own	8.20%	Shs Outstand	124.79M	Perf Week	13.30%
Market Cap	285.87M	Forward P/E	-	EPS next Y	-0.76	Insider Trans	0.44%	Shs Float	90.46M	Perf Month	4.55%
Income	-57.90M	PEG	-	EPS next Q	-0.17	Inst Own	45.50%	Short Float / Ratio	0.99% / 6.39	Perf Quarter	46.50%
Sales	-	P/S	-	EPS this Y	-14.90%	Inst Trans	-1.78%	Short Interest	0.89M	Perf Half Y	9.52%
Book/sh	2.52	P/B	0.91	EPS next Y	0.00%	ROA	-15.80%	Target Price	5.00	Perf Year	-43.35%
Cash/sh	1.48	P/C	1.55	EPS next 5Y	-	ROE	-17.50%	52W Range	1.50 - 5.07	Perf YTD	27.78%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-54.59%	Beta	-
Dividend %	-	Quick Ratio	27.60	Sales past 5Y	-	Gross Margin	-	52W Low	53.33%	ATR	0.15
Employees	134	Current Ratio	27.60	Sales Q/Q	-	Oper. Margin	-	RSI (14)	61.03	Volatility	8.59% 7.68%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	20.00%	Profit Margin	-	Rel Volume	2.73	Prev Close	2.26
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Feb 23 BMO	Payout	-	Avg Volume	139.83K	Price	2.30
Recom	2.20	SMA20	8.34%	SMA50	13.73%	SMA200	1.82%	Volume	381,563	Change	1.77%

Jan-06-22

Initiated

Morgan Stanley

Equal-Weight

Nov-02-21

Initiated

Cowen

Outperform

Aug-04-21

Initiated

Goldman

Neutral

$10

Jul-13-21

Initiated

Jefferies

Buy

$13

Mar-07-23 08:00AM	Nautilus Biotechnology Announces First Access Challenge Winners GlobeNewswire
Feb-23-23 06:05AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results GlobeNewswire -7.00%
Feb-21-23 08:00AM	Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference GlobeNewswire -10.31%
Jan-26-23 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 GlobeNewswire
07:45AM	Nautilus Biotechnology Expands to San Diego GlobeNewswire
08:00AM	Loading…
Jan-19-23 08:00AM	Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG) GlobeNewswire
Nov-16-22 08:00AM	Nautilus Biotechnology Launches First Access Challenge GlobeNewswire -6.47%
Nov-01-22 06:05AM	Nautilus Biotechnology Reports Third Quarter 2022 Financial Results GlobeNewswire
Oct-05-22 08:00AM	Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022 GlobeNewswire -7.26%
Sep-23-22 08:00AM	Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit GlobeNewswire
Sep-01-22 08:00AM	Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board GlobeNewswire
Aug-30-22 08:00AM	Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-11-22 06:30AM	Sujal Patel Is The Co-Founder of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) And Just Spent US$146k On Shares Simply Wall St.
Aug-02-22 06:48AM	Nautilus Biotechnology Reports Second Quarter 2022 Financial Results GlobeNewswire
Aug-01-22 04:05PM	Nautilus Biotechnology Appoints Eric Spence as Vice President of Instrument Engineering and Ken Kuhn, Ph.D., as Vice President of Reagent and Platform Development GlobeNewswire
08:00AM	Loading…
Jul-13-22 08:00AM	Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022 GlobeNewswire
May-12-22 06:28AM	Trade Alert: The Co-Founder Of Nautilus Biotechnology, Inc. (NASDAQ:NAUT), Sujal Patel, Has Just Spent US$198k Buying A Few More Shares Simply Wall St. +6.81%
May-03-22 06:00AM	Nautilus Biotechnology Reports First Quarter 2022 Financial Results GlobeNewswire
Apr-12-22 08:00AM	Nautilus Biotechnology Appoints Gwen Weld as Chief People Officer and Sheri Wilcox, Ph.D., as Vice President of Affinity Reagent Development GlobeNewswire
Apr-07-22 08:00AM	Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022 GlobeNewswire
Apr-04-22 08:00AM	Nautilus Biotechnology to Present at EuPA and AACR Meetings GlobeNewswire
Mar-31-22 04:05PM	Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors GlobeNewswire
Mar-05-22 07:22AM	What Percentage Of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Shares Do Insiders Own? Simply Wall St.
Feb-24-22 06:00AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results GlobeNewswire +8.43%
Feb-16-22 04:05PM	Nautilus to Participate in the 42nd Annual Cowen Health Care Conference GlobeNewswire
Feb-02-22 01:38PM	Clarius Group, LLC Buys BTC BlackRock Ultra Short-Term Bond ETF, , Vanguard Ultra-Short Bond ... GuruFocus.com
Jan-27-22 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022 GlobeNewswire -6.75%
Dec-16-21 01:07PM	A look at insider stock sales among Portland-area companies in 2021 (Photos) American City Business Journals
Dec-05-21 06:39AM	Insider Buying: The Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Co-Founder Just Bought 1.5% More Shares Simply Wall St.
Nov-02-21 08:00AM	Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome GlobeNewswire +7.17%
08:00AM	Loading…
08:00AM	Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome CNW Group
06:00AM	Nautilus Biotechnology Reports Third Quarter 2021 Financial Results GlobeNewswire
Oct-11-21 08:00AM	Nautilus Biotechnology to Announce Third Quarter of Fiscal Year 2021 Financial Results on November 2, 2021 GlobeNewswire
Sep-10-21 10:21AM	Do Insiders Own Lots Of Shares In Nautilus Biotechnology, Inc. (NASDAQ:NAUT)? Simply Wall St.
Sep-03-21 09:00AM	Nautilus to Participate in the Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-10-21 06:00AM	Nautilus Biotechnology Reports Second Quarter 2021 Financial Results GlobeNewswire -5.01%
Aug-09-21 08:00AM	Nautilus Biotechnology Appoints Karl Voss, Ph.D., as Vice President of Life Sciences Research and Development GlobeNewswire +6.68%
Jul-13-21 08:00AM	Nautilus Biotechnology to Announce Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021 GlobeNewswire
Jun-17-21 07:00AM	Nautilus Biotechnology Appoints Emma Lundberg, Ph.D., to Scientific Advisory Board GlobeNewswire

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was incorporated in 2016 and is headquartered in Seattle, Washington.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sankar Subramanian	Senior VP, Product Development	Sep 27	Buy	2.03	5,000	10,149	91,250	Sep 28 04:01 PM
Sankar Subramanian	Senior VP, Product Development	Sep 26	Buy	2.02	10,000	20,250	86,250	Sep 28 04:01 PM
Weld Gwen E	Chief People Officer	Sep 23	Buy	2.03	30,000	60,765	30,000	Sep 26 09:26 PM
Sankar Subramanian	Senior VP, Product Development	Sep 16	Buy	2.16	35,000	75,446	75,000	Sep 19 05:50 PM
Sankar Subramanian	Senior VP, Product Development	Sep 15	Buy	2.19	40,000	87,752	40,000	Sep 19 05:50 PM
Mowry Anna	CFO and Treasurer	Aug 19	Buy	2.30	17,500	40,218	56,750	Aug 22 07:40 PM
Murphy Matthew B.	General Counsel	Aug 15	Buy	2.84	7,500	21,308	54,140	Aug 16 08:19 PM
Murphy Matthew B.	General Counsel	Aug 12	Buy	2.85	2,500	7,125	46,640	Aug 16 08:19 PM
Patel Sujal M	CEO, President, and Secretary	Aug 08	Buy	2.93	8,346	24,444	10,014,488	Aug 08 07:48 PM
Patel Sujal M	CEO, President, and Secretary	Aug 05	Buy	2.92	41,654	121,646	10,006,142	Aug 08 07:48 PM
Mowry Anna	CFO and Treasurer	Jun 27	Buy	2.75	5,500	15,124	39,250	Jun 28 06:17 PM
Patel Sujal M	CEO, President, and Secretary	May 09	Buy	3.96	50,000	198,000	9,964,488	May 10 08:28 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience